PHARMASUST 300

Description

Testosterone PROPIONATE 36 mg/ml Testosterone PHENYLPROPIONATE 72 mg/ml Testosterone ISOCAPROATE 72 mg/ml Testosterone DECANOATE 120 mg/ml PHARMASUST 300 – PHARMACOM LABS 1 VIAL X 10 ML X 300 MG/ML PHARMASUST 300, a trade version of the classic Sustanon® by Pharmacom Labs, is a testosterone blend that comprises four different testosterone esters. This formulation is designed to provide a fast yet extended release of testosterone. Notably, PHARMASUST 300 is manufactured using advanced technologies for high-percentage drug synthesis, resulting in a 20% higher concentration of the active agent per milliliter compared to the standard Sustanon® version. Effects: Muscle Building: All forms of testosterone, including PHARMASUST 300, are recognized for their potent muscle-building effects, making them a vital component of both mass building and cutting cycles. Overall Health: Testosterone plays a pivotal role in promoting overall health and well-being. It influences factors such as libido, energy, immunity, fat loss, muscle gain and preservation, and potential prevention of Osteoporosis and heart disease. Cognitive Function: Testosterone influences cognitive functions, including attention, memory, and spatial ability. Low testosterone levels may be linked to cognitive decline. Cardiovascular Health: Maintaining higher testosterone levels in elderly men has been associated with improved parameters that reduce the risk of cardiovascular disease, including increased lean body mass, reduced visceral fat mass, lower total cholesterol, and better glycemic control. Behavior and Mood: Testosterone has a significant impact on behavior, mood, and even choices in career and romantic relationships. Potential Side Effects: Androgenic Effects: The use of PHARMASUST 300 may lead to androgenic side effects, such as acne, hair loss, and an increased risk of benign prostatic hyperplasia (BPH). Hormone Conversion: In men, approximately 5% of testosterone undergoes 5α-reduction to form the more potent androgen dihydrotestosterone (DHT). Additionally, about 0.3% of testosterone is converted into estradiol, the primary female sex hormone, by the enzyme aromatase. Precautions are recommended to mitigate these side effects, including the use of aromatase inhibitors on cycle (preferably anastrozole) and selective estrogen receptor modulators (SERMs) like clomifene or toremifene during post-cycle therapy (PCT). Dosage Instructions: Dosage recommendations for PHARMASUST 300 may vary based on individual goals and experience levels. Consultation with a healthcare professional is advisable to determine the most appropriate regimen. Precautions and monitoring, as suggested in the potential side effects section, should be followed to ensure the responsible use of PHARMASUST 300.